胰島素樣生長因子-1受體(IGF-IR)是一種在質(zhì)膜中發(fā)現(xiàn)的受體酪氨酸激酶,,它會介導(dǎo)IGF-1(這是一種參與促進(jìn)細(xì)胞生長和增殖的蛋白質(zhì)激素)的作用。異常的IGF-1R信號傳導(dǎo)與多種癌癥有關(guān),。
在2010年2月9日刊的Science Signaling的一篇Research Article中,Sehat 等人研究顯示,,IGF-1可刺激一種叫作SUMOylation的IGF-1R的修飾,,這種修飾可使該受體能夠被轉(zhuǎn)運(yùn)到細(xì)胞核,并在那里與特別的DNA序列結(jié)合以增進(jìn)標(biāo)靶基因的表達(dá),。IGF-1R的這些核效應(yīng)不同于其在質(zhì)膜上的信號傳導(dǎo),,它可能與IGF-1在癌癥中的作用有關(guān)。(生物谷Bioon.com)
生物谷推薦原始出處:
Sci. Signal., 9 February 2010 DOI: 10.1126/scisignal.2000628
SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor
Bita Sehat1, Ali Tofigh2*, Yingbo Lin1*, Eric Trocmé1, Ulrika Liljedahl3, Jens Lagergren2, and Olle Larsson1
1 Department of Oncology and Pathology, Karolinska Institutet, Cancer Center Karolinska, R8:04, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
2 KTH Royal Institute of Technology, Computational Biology, Stockholm Bioinformatics Centre, SE-100 44 Stockholm, Sweden.
3 Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden.
Abstract: The insulin-like growth factor 1 receptor (IGF-1R) plays crucial roles in developmental and cancer biology. Most of its biological effects have been ascribed to its tyrosine kinase activity, which propagates signaling through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Here, we report that IGF-1 promotes the modification of IGF-1R by small ubiquitin-like modifier protein–1 (SUMO-1) and its translocation to the nucleus. Nuclear IGF-1R associated with enhancer-like elements and increased transcription in reporter assays. The SUMOylation sites of IGF-1R were identified as three evolutionarily conserved lysine residues—Lys1025, Lys1100, and Lys1120—in the β subunit of the receptor. Mutation of these SUMO-1 sites abolished the ability of IGF-1R to translocate to the nucleus and activate transcription but did not alter its kinase-dependent signaling. Thus, we demonstrate a SUMOylation-mediated mechanism of IGF-1R signaling that has potential implications for gene regulation.